Anthony Baron from Charles River Associates identified the factors that restrict access to MS treatment in Europe.
A presentation on the role of the European Patients’ Academy on Therapeutic Innovation (EUPATI).
A seminar on Better access to therapies and care in Central and Eastern European countries, organised by EMSP in November 2010, in...
Health economist Gisela Kobelt presented the Time Matter in MS study at EMSP’s 2016 Spring Conference.
There was a problem reporting this post.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.